These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28157697)

  • 1. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
    Tao Y; Yang G; Yang H; Song D; Hu L; Xie B; Wang H; Gao L; Gao M; Xu H; Xu Z; Wu X; Zhang Y; Zhu W; Zhan F; Shi J
    Oncotarget; 2017 Apr; 8(16):26718-26731. PubMed ID: 28157697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.
    Marks DH; Thomas R; Chin Y; Shah R; Khoo C; Benezra R
    Cell Rep; 2017 May; 19(9):1832-1845. PubMed ID: 28564602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
    Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
    Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIP13 Functions in the Establishment of the Spindle Assembly Checkpoint by Replenishing O-MAD2.
    Ma HT; Poon RYC
    Cell Rep; 2018 Feb; 22(6):1439-1450. PubMed ID: 29425500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching.
    Ye Q; Rosenberg SC; Moeller A; Speir JA; Su TY; Corbett KD
    Elife; 2015 Apr; 4():. PubMed ID: 25918846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for remodelling of the cell cycle checkpoint protein MAD2 by the ATPase TRIP13.
    Alfieri C; Chang L; Barford D
    Nature; 2018 Jul; 559(7713):274-278. PubMed ID: 29973720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
    Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
    J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of interaction of TRIP13 AAA-ATPase with the Mad2-binding protein p31comet and with mitotic checkpoint complexes.
    Miniowitz-Shemtov S; Eytan E; Kaisari S; Sitry-Shevah D; Hershko A
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11536-40. PubMed ID: 26324890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insight into TRIP13-catalyzed Mad2 structural transition and spindle checkpoint silencing.
    Brulotte ML; Jeong BC; Li F; Li B; Yu EB; Wu Q; Brautigam CA; Yu H; Luo X
    Nat Commun; 2017 Dec; 8(1):1956. PubMed ID: 29208896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conserved AAA-ATPase PCH-2
    Défachelles L; Russo AE; Nelson CR; Bhalla N
    Mol Biol Cell; 2020 Sep; 31(20):2219-2233. PubMed ID: 32697629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein.
    Wang K; Sturt-Gillespie B; Hittle JC; Macdonald D; Chan GK; Yen TJ; Liu ST
    J Biol Chem; 2014 Aug; 289(34):23928-37. PubMed ID: 25012665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
    Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
    Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
    Wang Y; Huang J; Li B; Xue H; Tricot G; Hu L; Xu Z; Sun X; Chang S; Gao L; Tao Y; Xu H; Xie Y; Xiao W; Yu D; Kong Y; Chen G; Sun X; Lian F; Zhang N; Wu X; Mao Z; Zhan F; Zhu W; Shi J
    Cancer Res; 2020 Feb; 80(3):536-548. PubMed ID: 31732653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIP13 Regulates Both the Activation and Inactivation of the Spindle-Assembly Checkpoint.
    Ma HT; Poon RYC
    Cell Rep; 2016 Feb; 14(5):1086-1099. PubMed ID: 26832417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway.
    Gao Y; Liu S; Guo Q; Zhang S; Zhao Y; Wang H; Li T; Gong Y; Wang Y; Zhang T; Dong Z; Bacich D; Chowdhury WH; Rodriguez R; Wang Z
    Int J Biol Sci; 2019; 15(7):1488-1499. PubMed ID: 31337978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
    Niu L; Gao Z; Cui Y; Yang X; Li H
    Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
    Wang Y; Dong S; Hu K; Xu L; Feng Q; Li B; Wang G; Chen G; Zhang B; Jia X; Xu Z; Gao X; Zhang H; Xie Y; Lu M; Chang S; Song D; Wu X; Jia Q; Zhu H; Zhou J; Zhu W; Shi J
    J Transl Med; 2023 Nov; 21(1):858. PubMed ID: 38012658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
    Agarwal S; Behring M; Kim HG; Chandrashekar DS; Chakravarthi BVSK; Gupta N; Bajpai P; Elkholy A; Al Diffalha S; Datta PK; Heslin MJ; Varambally S; Manne U
    Mol Oncol; 2020 Dec; 14(12):3007-3029. PubMed ID: 33037736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
    Li C; Xia J; Franqui-Machin R; Chen F; He Y; Ashby TC; Teng F; Xu H; Liu D; Gai D; Johnson SK; van Rhee F; Janz S; Shaughnessy JD; Tricot G; Frech I; Zhan F
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of the spindle-assembly checkpoint promotes spindle poison-mediated cytotoxicity with distinct kinetics.
    Zeng X; Xu WK; Lok TM; Ma HT; Poon RYC
    Cell Death Dis; 2019 Apr; 10(4):314. PubMed ID: 30952840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.